Review Article
New Progress of Epigenetic Biomarkers in Urological Cancer
Table 3
Overview of prostate cancer biomarkers.
| Biomarker | Sample | Type | Diagnosis, treatment, or prognosis |
| Prostate cancer |
| PCDH17, TCF21 | Tissue | DNA methylation | Diagnosis | GSTP1, ARF, CDNK2A, MGMT | Urine | DNA methylation | Diagnosis | GSTP1, APC, RARB2, RASSF1A | Urine | DNA methylation | Diagnosis | GSTP1, PTGS2, RPRM, TIG1 | Tissue (serum) | DNA methylation | Diagnosis | HOXB13 | Tissue | Overexpression | Prognosis | ADAM19 | Tissue | Overexpression | Treatment | SFRP1 | Tissue | Decreased expression | Diagnosis, prognosis | PSF1 | Tissue | Overexpression | Diagnosis, prognosis | EN2 | Tissue, urine | Overexpression | Diagnosis | SLC18A2 | Tissue | Downregulated | Diagnosis | TRPM4 | Tissue | Overexpression | Prognosis | SUX2 | Tissue | Downregulated | Prognosis | XPO6 | Tissue | Overexpression | Prognosis |
|
|